These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 5989387)

  • 1. [Disorders ofcobalt metabolism in patients with chronic hepatitis and the therapeutic use of this trace element].
    Ol'gina FP
    Klin Med (Mosk); 1966 May; 44(5):132-4. PubMed ID: 5989387
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effectiveness of several methods of treating viral hepatitis].
    Zavgorodniĭ VI
    Vrach Delo; 1977 Feb; (2):132-4. PubMed ID: 860443
    [No Abstract]   [Full Text] [Related]  

  • 3. [Experimental clinical research on the therapeutic action of AM 65234].
    Forattini C; Pulliero G
    Clin Ter; 1966 Jul; 38(1):55-68. PubMed ID: 5990473
    [No Abstract]   [Full Text] [Related]  

  • 4. Serum molybdenum in diseases of the liver and biliary system.
    Versieck J; Hoste J; Vanballenberghe L; Barbier F; Cornelis R; Waelput I
    J Lab Clin Med; 1981 Apr; 97(4):535-44. PubMed ID: 7205061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapeutic effectiveness of lidase in chronic forms of infectious hepatitis].
    Svirid GM
    Vrach Delo; 1967 Oct; 10():101-2. PubMed ID: 5618981
    [No Abstract]   [Full Text] [Related]  

  • 6. [Prednisolone therapy of patients with chronic hepatitis and cirrhosis of the liver].
    Vasil'eva LN
    Klin Med (Mosk); 1966 May; 44(5):42-8. PubMed ID: 5990929
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of prednisone treatment in the acute phase of viral hepatitis on the incidence of late post-hepatitic hepatorpathy from 1 to 3 years after the disease. (Statistical evaluation of 187 cases)].
    Da Villa G; Fiorentino F; Piccinino F
    G Mal Infett Parassit; 1966 Dec; 18(12):835-40. PubMed ID: 5998986
    [No Abstract]   [Full Text] [Related]  

  • 8. [Use of cobalt chloride in the overall treatment of inflammatory diseases of the female genitalia].
    Shein Sv
    Pediatr Akus Ginekol; 1977; (1):56-7. PubMed ID: 882304
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapeutic effectiveness of BK-8 in the patients with infectious hepatitis].
    Shemonaev VI
    Vrach Delo; 1967 Oct; 10():95-7. PubMed ID: 5619030
    [No Abstract]   [Full Text] [Related]  

  • 10. [On the problem of effects and side effects of steroids and liver hydrolysates in acute and chronic liver diseases].
    Kleine FD
    Z Arztl Fortbild (Jena); 1966 Aug; 60(15):900-4. PubMed ID: 5995281
    [No Abstract]   [Full Text] [Related]  

  • 11. [On the therapy of chronic inflammatory liver diseases without or with vitamin B 12-folic acid].
    Burgmann W
    Munch Med Wochenschr; 1966 Sep; 108(37):1805-8. PubMed ID: 6014771
    [No Abstract]   [Full Text] [Related]  

  • 12. [Course of infectious hepatitis in patients with biliary tract lambliasis].
    Telichko AA; Mirzoian MA; Nersesova AG
    Voen Med Zh; 1973 Feb; 2():56-7. PubMed ID: 4765545
    [No Abstract]   [Full Text] [Related]  

  • 13. [Primary choledochitis as a complication of infectious hepatitis].
    Tkacz B; Fabianowski J
    Przegl Lek; 1967; 23(4):378-80. PubMed ID: 6043458
    [No Abstract]   [Full Text] [Related]  

  • 14. Promoting hepatic growth factor in the treatment of heavy type hepatitis and severe chronic hepatitis: a multicenter clinical study.
    Xu JH; Yu YY; Si CW; Zeng Z; Wang QH; Luo DD; Zhou YX; Zeng MD; Qiao GY; Yao JL; Lu WL
    Hepatobiliary Pancreat Dis Int; 2004 Aug; 3(3):381-5. PubMed ID: 15313673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of the therapeutic effect of aikamine and guronsan in epidemic hepatitis].
    Semendiaeva ME; Tareeva IE; Guseva TM; Liakishev AA; Rozanova LB
    Sov Med; 1967 Jun; 30(6):39-44. PubMed ID: 5611356
    [No Abstract]   [Full Text] [Related]  

  • 16. [The effect of socioeconomic status on the prevalence of biliary tract diseases in the Evens and Evenki].
    Sedov KR; Tsukanov VV; Kishinevskiĭ VA
    Ter Arkh; 1993; 65(2):42-4. PubMed ID: 9133009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum antibodies to enterohepatic Helicobacter spp. in patients with chronic liver diseases and in a population with high prevalence of H. pylori infection.
    Vorobjova T; Nilsson I; Terjajev S; Granholm M; Lyyra M; Porkka T; Prükk T; Salupere R; Maaroos HI; Wadström T; Uibo R
    Dig Liver Dis; 2006 Mar; 38(3):171-6. PubMed ID: 16464652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Determination of blood serum 5'-nucleotidase activity in differential diagnosis of jaundice].
    Braginskiĭ DM; Paktoris EA; Sinaĭko GA; Shakhgil'ian IV
    Sov Med; 1980; (6):49-52. PubMed ID: 6251570
    [No Abstract]   [Full Text] [Related]  

  • 19. [Chronic active hepatitis].
    Etienne JP; Gueroult N; Chaput JC
    Nouv Presse Med; 1972 Dec; 1(46):3133. PubMed ID: 4650516
    [No Abstract]   [Full Text] [Related]  

  • 20. Liver transplantation in precirrhotic biliary tract disease: Portal hypertension is frequently associated with nodular regenerative hyperplasia and obliterative portal venopathy.
    Abraham SC; Kamath PS; Eghtesad B; Demetris AJ; Krasinskas AM
    Am J Surg Pathol; 2006 Nov; 30(11):1454-61. PubMed ID: 17063088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.